Font Size: a A A

The Effect Of TiaozhiJi Emulsion On Insulin Resistance Of The Fatty Liver Rat

Posted on:2009-04-08Degree:MasterType:Thesis
Country:ChinaCandidate:K X LuoFull Text:PDF
GTID:2144360272464719Subject:Chinese medical science
Abstract/Summary:PDF Full Text Request
Objective To establish a hepatic fibrosis model in rat according to multiple factors, compound factors rat fatty liver model by observing TiaozhiJi Emulsion on experimental plot in TC,TG,HDL-C,LDL-C,FBG,ALT,GGT,FLNS,the liver and liver pathology index Detection of such indicators,and calculate HOMA-IR = FBG * FINS/22.5.TiaozhiJi Emulsion of this fatty liver of the validity,reliability,and insulin resistance in the formation of fatty liver's role in the process.Methods 52 Wistar male rats,a week after the laboratory feeding adaptation,randomized divided into five groups,the control group,the control group model of fatty liver,fatty liver model of good easy-treatment group,fatty liver Model medicine TiaozhiJi Emulsion treatment group,fatty liver model of traditional Chinese medicine(Liuwei- dihuang pill) in the treatment group.Combined high-fat emulsion used alcohol fatty liver rat model to Essentiale and Liuweidihuangwan to as a positive control,the use of automatic biochemical analyzer detected TC,TG,HDL-C,LDL-C,ALT and GGT,FBG,using enzyme-linked immunosorbent assay for determination of serum insulin levels.B islet cell function evaluation by homeostasis model assessment(HOMA),or insulin resistance index (HOMA-IR) =(FBG) * FINS/22.5.Results The TC,TG,LDL-C,ALT and GGT,FBG,FINS,HOMA-IR,liver index were higher than those of the normal group,lower HDL-C group.TiaozhiJi Emulsion can reduce the liver index,lower ALT and GGT,TC,TG,LDL-C,FBG,FINS content,lower HOMA-IR.Conclusion TiaozhiJi Emulsion control the mechanism of fatty liver:1.TiaozhiJi Emulsion protect liver cells,and restoration of stability and structure of mitochondrial membrane such as the liver cell functions,and improve liver function.2.TiaozhiJi Emulsion can improve blood lipid metabolism disorders,prevention and treatment of hyperlipidemia. 3.TiaozhiJi Emulsion can improve islet B-cell secretion of the high state and decrease insulin secretion,improving the body's sensitivity to insulin and improve insulin resistance.4.TiaozhiJi Emulsion can reduce rat liver liver index,reduced fat deposition in the liver and improve the role of fatty degeneration of the liver...
Keywords/Search Tags:Fatty Liver, Insulin Resistance, Traditional Chinese Medicine and Pharmacology, Rat
PDF Full Text Request
Related items
The Pathogenesis Of Insulin Resistance In Rats With Nonalcoholic Fatty Liver Disease And The Effects Of Traditional Chinese Medicine On Them
Experimental Study Of Compound Traditional Chinese Medicine Treatment Of Nonalcoholic Fatty Liver Disease
Based On Network Pharmacology To Analyze The Mechanism Of Chinese Medicine For Nourishing Qi, Promoting Blood Circulation And Resolving Phlegm To Improve Insulin Resistance In Coronary Heart Disease
Correlation Between Adiponectin,Tumor Necrosis Factor-a,Insulin Resistance And Traditional Chinese Medicine Syndrome Differentiation Typing In Patients With Nonalcoholic Fatty Liver
Medication Regularity And Mechanisms Of Traditional Chinese Medicine In Im Proving Insulin Resistance Of Non-alcoholic Fatty Liver Disease:A Study Based On Data Mining And Network Pharmacology
Network Pharmacology Study Of Professor Lu Bingjiu's Traditional Chinese Medicine Treatment Of MAFLD Based On Data Minin
The Association Between Syndrome Differentiation Of Traditional Chinese Medicine And Insulin Resistance In Type 2 Diabetes Mellitus With Non-alcoholic Fatty Liver Disease
Exploring The Medication Rules And Mechanism Of Action Of Traditional Chinese Medicine In The Treatment Of Non-alcoholic Fatty Liver Disease Based On Literature Data Mining And Network Pharmacolog
Preventing And Treating Effects Of Traditional Chinese Medicine Compound GST On Fatty Liver
10 Effects Of Qingfei Xiegan Decoction Of The Traditional Chinese Korean Medicine On AMPK Signaling Pathway In Type 2 Diabetic With Nonalcoholic Fatty Liver Disease Rats